IMNM compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

IMNMImmunome Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

IMNMImmunome Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

IMNMImmunome Inc.

18.17▼−6.92%

Mkt cap$2.2BRevenue$4MQ2 FY25Revenue$9MFY24

LLYELI Lilly & Co

1,386.51▼−2.22%

Regular sessionNov 5 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Regular sessionNov 5 '26

IMNMImmunome Inc.

LLYELI Lilly & Co

18.17▼−6.92%

Price

1,386.51▼−2.22%

$2.2B

Mkt cap

$1.3T

Q2 FY25$4M

Revenue

$24.4BQ3 FY26

FY24$9M

Revenue

$65.2BFY25

IMNM18.17▼−6.92%vsLLY1,386.51▼−2.22%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMNM: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMNM 5

ABBVAbbVie Global Enterprisescustomer

BMYBristol-Myers Squibbsupplier

ZNTLZentalis Pharmaceuticalssupplier

—Ayala Pharmaceuticalsunlistedsupplier

1 more · IMNM chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

IMNM, solidLLY, dashed